Earnings Highlights: Social media users noted Verisk Analytics reported modest Q1 2026 revenue growth of 3.9% alongside adjusted EPS gains of 5.2%. Observers highlighted the company's P/E ratio at 30x, down 32% from its five-year average, underscoring a potential shift in valuation dynamics.
Acquisition News: Discussions centered on Verisk's acquisition of McKenzie Intelligence Solutions, which delivered a 3x return for an exiting investor. Participants emphasized how such moves strengthen Verisk's data capabilities in geospatial intelligence.
Analyst Moves: Recent posts referenced an upgraded price target from UBS, now at 235, maintaining a neutral stance. Traders also shared technical setups suggesting a potential rebound amid light trading volumes and reaffirmed guidance.
Note: This discussion summary was generated from an AI condensation of post data.
Verisk Analytics Insider Trading Activity
Verisk Analytics insiders have traded $VRSK stock on the open market 14 times in the past 6 months. Of those trades, 2 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $VRSK stock by insiders over the last 6 months:
- SAMUEL G LISS has made 0 purchases and 2 sales selling 11,436 shares for an estimated $2,052,769.
- LEE SHAVEL (Chief Executive Officer) has made 0 purchases and 2 sales selling 6,035 shares for an estimated $1,246,182.
- BRUCE EDWARD HANSEN has made 0 purchases and 2 sales selling 4,671 shares for an estimated $809,252.
- KATHY CARD BECKLES (Chief Legal Officer) sold 2,020 shares for an estimated $394,889
- ELIZABETH MANN (Chief Financial Officer) has made 0 purchases and 5 sales selling 2,000 shares for an estimated $362,860.
- KIMBERLY S STEVENSON purchased 1,000 shares for an estimated $179,200
- GREGORY HENDRICK purchased 500 shares for an estimated $90,080
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Verisk Analytics Revenue
Verisk Analytics had revenues of $806.3M in Q2 2026. This is an increase of 4.36% from the same period in the prior year.
You can track VRSK financials on Quiver Quantitative's VRSK stock page.
You can access data on VRSK stock through the Quiver Quantitative API.
Verisk Analytics Congressional Stock Trading
Members of Congress have traded $VRSK stock 5 times in the past 6 months. Of those trades, 4 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $VRSK stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 4 times. They made 3 purchases worth up to $45,000 on 06/16, 05/15, 02/10 and 1 sale worth up to $15,000 on 04/14.
- SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/27.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
Verisk Analytics Hedge Fund Activity
We have seen 423 institutional investors add shares of Verisk Analytics stock to their portfolio, and 535 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL INTERNATIONAL INVESTORS added 2,865,313 shares (+87.8%) to their portfolio in Q1 2026, for an estimated $544,352,163
- FMR LLC removed 2,217,247 shares (-85.5%) from their portfolio in Q1 2026, for an estimated $421,232,585
- PARNASSUS INVESTMENTS, LLC removed 1,760,761 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $316,109,422
- ALLIANCEBERNSTEIN L.P. added 1,710,895 shares (+30.9%) to their portfolio in Q1 2026, for an estimated $325,035,832
- BROWN ADVISORY INC removed 1,458,098 shares (-97.5%) from their portfolio in Q1 2026, for an estimated $277,009,458
- CITADEL ADVISORS LLC added 1,417,985 shares (+244.8%) to their portfolio in Q1 2026, for an estimated $269,388,790
- FOCUS PARTNERS WEALTH added 1,411,367 shares (+3687.3%) to their portfolio in Q1 2026, for an estimated $268,131,502
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Verisk Analytics Government Contracts
We have seen $16,501,853 of award payments to $VRSK over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- TRANSITION THE CRS OPERATIONS FROM CONTRACTOR TO GOVERNMENT STAFF, ENSURING TRANSFER OF ALL RECORDS, DATA, ...: $11,169,016
- THE OFFICE OF CHILD SUPPORT SERVICES (OCSS) INSURANCE MATCH (IM) PROGRAM IS A TOOL TO ASSIST STATE IV-D AGE...: $4,103,328
- TRIP CLAIMS SYSTEM: $718,028
- TRIP DATA COLLECTION AND ANALYSIS: $473,350
- INSURANCE SYMBOL GROUP DATA FROM THE INSURANCE SERVICE ORGANIZATION (ISO) TO BE USED IN QUALITY ADJUSTMENT ...: $38,130
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
Verisk Analytics Price Targets
Multiple analysts have issued price targets for $VRSK recently. We have seen 7 analysts offer price targets for $VRSK in the last 6 months, with a median target of $230.0.
Here are some recent targets:
- Joshua Dennerlein from B of A Securities set a target price of $190.0 on 05/19/2026
- Andrew Steinerman from JP Morgan set a target price of $230.0 on 04/30/2026
- Ashish Sabadra from RBC Capital set a target price of $230.0 on 03/30/2026
- Jason Haas from Wells Fargo set a target price of $240.0 on 03/02/2026
- C. Gregory Peters from Raymond James set a target price of $260.0 on 03/02/2026
- David Motemaden from Evercore ISI Group set a target price of $216.0 on 02/19/2026
- Andre Benjamin from Goldman Sachs set a target price of $206.0 on 02/19/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
